Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCa1.1 (KCNMA1) is the alpha subunit of the calcium-activated BK (Big Potassium) channel, a large conductance potassium channel activated by membrane depolarization and increases in intracellular calcium. It plays a crucial role in regulating smooth muscle tone, neuronal excitability, neurotransmitter release, and auditory processing. Dysfunction of KCa1.1 is associated with neurological disorders such as paroxysmal nonkinesigenic dyskinesia, epilepsy, and Liang-Wang syndrome.
Potassium channel modulation; affects membrane hyperpolarization and excitability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium calcium-activated channel subfamily M alpha member 1 (KCa1.1).